Nanovex Biotechnologies

A 100% Spanish owned biotechnological company specialising in the design, development and manufacture of nano-systems for drug delivery applications. Our technology is focussed on applications in the field of medicine where we develop systems to diagnose and treat illnesses. Nanovex biotechnologies is a spin-off of University of Oviedo founded by Rebeca Alonso and Daniel Pando with the support of multiple professors in Chemistry as well as Química del Nalón in November 2014. Nanovex has become a part of Quimica del Nalón, a private and independent company whose core activity is the carbochemical sector. In 2017, Indermal, the cosmetic division of Nanovex is born to apply the nanotechnology to the encapsulation of actives to dermocosmetics.